Merck - About the company
Merck is a public company based in Darmstadt (Germany), founded in 1668 by Frederic Berkermann, Joachim Reiß and Friedrich Jacob Merck. It operates as a Provider of drug research and development services for multiple therapeutic areas. Merck has raised an undisclosed amount in funding. The company has 1989 active competitors, including 102 funded and 208 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.
Company Details
Provider of drug research and development services for multiple therapeutic areas. It delivers personalized treatments for serious diseases, and progressive treatment solutions. It also offers diagnostic, and cosmetic products, along with semiconductors and optoelectronics.
- Website
- merckgroup.com
- Email ID
- *****@merckgroup.com
- Phone Number
- +49 **********
- Registered Address
- Godrej One, 8th Floor, Pirojshanagar, Eastern Express Highway, Vikhroli - East, Mumbai City, Mumbai, Maharashtra, India, 400079
Key Metrics
Founded Year
1668
Location
Darmstadt, Germany
Stage
Public
Latest Funding Round
Investors
Ranked
2nd among 1989 active competitors
Annual Revenue
€1B+ as on Dec 31, 2023
Employee Count
11,142 as on Sep 30, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Merck
Merck is associated with 5 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MERCK A/S CIN: 21729310 , Denmark, Deadpooled | Nov 06, 1941 | - | - | |
Merck Kgaa CIN: HRB6164 , Germany, Active | Jul 17, 1995 | €1B+ (As on Dec 31, 2023) | 60348 (As on Dec 31, 2021) | |
MERCK PERFORMANCE MATERIALS PRIVATE LIMITED CIN: U46521MH1987PTC043235 , India, Active | Apr 23, 1987 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 49 (As on Mar 01, 2026) | |
MERCK SPECIALITIES PRIVATE LIMITED CIN: U24100MH2005PTC152680 , India, Active | Apr 18, 2005 | ₹1,000+ Cr (As on Mar 31, 2025) | 1079 (As on Mar 01, 2026) | |
MERCK LIFE SCIENCE PRIVATE LIMITED CIN: U33100MH1986PTC221693 , India, Active | Sep 03, 1986 | ₹1,000+ Cr (As on Mar 31, 2025) | 569 (As on May 01, 2026) |
Merck's IPO details
Merck got listed on Apr 20, 1949.
Click here to take a look at Merck's IPO in detail
Sign up to download Merck's company profile
Merck's funding and investors
Merck has raised funding over 34 rounds. Its first funding round was on Jan 01, 2014. Its latest funding round was a Grant (prize money) round on Aug 11, 2023 for $*****. 1 investor participated in its latest round. Merck has 7 institutional investors.
Here is the list of recent funding rounds of Merck:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 11, 2023 | 2011495 | Grant (prize money) | 8301916 | 7309381 | 9032641 | 3641169 |
Aug 10, 2023 | 9078688 | Grant (prize money) | 8201173 | 8697170 | 6479445 | |
Dec 20, 2022 | 3970496 | Grant (prize money) | 7056539 | 9627265 | 3451861 |
View details of Merck's funding rounds and investors
Merck's founders and board of directors
Founder? Claim ProfileHere are the details of Merck's key team members:
- Frederic Berkermann: Commercial Lead Innovation Program Cultured Meat | Group Science & Technology Office of Merck. Contact Info: 1 email address
- Joachim Reiß: Director Business Development | Life Science | Process Solutions of Merck. Contact Info: 1 email address
- Friedrich Jacob Merck: Former Founder of Merck. Contact Info: 1 email address
View details of Merck's Founder profiles and Board Members
Merck's employee count trend
Merck has 11,142 employees as of Sep 26. Here is Merck's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Merck's Competitors and alternates
Top competitors of Merck include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Merck, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 83/100 | |
2nd | Provider of drug research and development services for multiple therapeutic areas | - | 62/100 | ||
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 81/100 | |
4th | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 79/100 | |
5th | AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 76/100 | |
6th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 75/100 | |
7th | Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 75/100 | |
8th | Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 71/100 | |
9th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
10th | Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 |
Looking for more details on Merck's competitors? Click here to see the top ones
Merck's Investments and acquisitions
Merck has made 21 investments in companies including Seeqc and IDRx. Merck has also acquired 19 companies including Bio-Techne and SpringWorks Therapeutics.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 25, 2026 | Acquisition | 1981 | Minneapolis (United States) | |
Apr 28, 2025 | Acquisition | 2017 | New York City (United States) | |
Jan 14, 2025 | Investments | 2019 | Elmsford (United States) |
See all investments and acquisitions by Merck
Reports related to Merck
Here is the latest report on Merck's sector:
News related to Merck
Media has covered Merck for a total of 62 events in the last 1 year, 25 of them have been about company updates and 10 about partnerships.
•
EMD Electronics Opens Semiconductor R&D Hub in Wisconsin to Accelerate InnovationVerdict•Oct 05, 2026•Merck
•
The Hashgraph Group and Merck: Cocoa Traceability SolutionsTechnologymagazine•Sep 08, 2026•Merck, The Hashgraph Group
•
Merck honors Korean scholars for display technology breakthroughs in AI era - The Korea TimesThe Korea Times•Aug 20, 2026•Merck
•
Bio-Techne Corporation Reports Fourth Quarter and Full Year Fiscal 2026 Financial ResultsPR Newswire•Aug 12, 2026•Bio-Techne, Merck
•
ICR and Merck KGaA Develop Pathfinder Molecules Targeting DHX8 in Cancer Drug DiscoveryEuropaWire•Aug 07, 2026•The Institute of Cancer Research, Merck
•
Merck KGaA to Adopt Evinova AI-Native Platform to Accelerate Clinical R&DContract Pharma•Jul 29, 2026•Evinova, Merck
•
Global New Material International's Cross-border Acquisition Recognized as Benchmark Case by Hong Kong Department of JusticeACN Newswire•Jul 29, 2026•Merck, Chesir
•
•
Merck Opens BioReliance® Testing Facility in Darmstadt to Support European Drug Product ReleaseGlobeNewswire•Jul 16, 2026•Merck
•
Cyllene Therapeutics Raises €33 Million Series CPulse 2.0•Jul 08, 2026•Cyllene Therapeutics, Merck, GordonMD Global Investments
Are you a Founder ?
FAQs about Merck
Explore our recently published companies
- Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
- Boooply - 2026 founded, Unfunded company
- Uaity - 2026 founded, Unfunded company
